Patent · US Expired

IGF-1 receptor interacting proteins

US6913883B2 · kind B2 · utility

1Cited by

1References

4Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Tanja Ligensa · Lohmar, DE
Ralf Schumacher · Penzberg, DE
Michael Weidner · Sunrise, US

Key dates

Filing date	Jul 30, 2001
Grant date	Jul 5, 2005
Priority date	—
Expiry date	Jan 3, 2022

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention comprises a nucleic acid molecule with the sequence SEQ ID NO:5 and the complementary sequence, and its use in diagnosis and therapy. This nucleic acid molecule (IIP-10) is a gene which encodes an IGF-1 receptor binding polypeptide.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.